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Background
There is a debate concerning serum iron markers in fungal infections in patients with different
diseases, and so far, none has assessed their level in fungal rhinosinusitis. Therefore, this
study aimed to detect whether allergic fungal rhinosinusitis is associated with alterations in
serum iron markers.

Patients and methods

Patients of this study were classified into two groups: group A included 35 patients with
allergic nasal polyps, and group B included 31 patients with allergic fungal rhinosinusitis.
Computerized tomography of paranasal sinuses was performed for all patients. Serum iron and
total iron‑binding capacity (TIBC) of all patients were measured, and unsaturated iron‑binding
capacity (UIBC) and transferrin saturation (TSAT) were calculated.

Results

Both the TIBC and UIBC were significantly higher in the allergic fungal rhinosinusitis group
than the nasal polyps group. No significant differences were detected in the levels of serum
iron and TSAT between the two groups.

Conclusion

Allergic fungal rhinosinusitis is associated with higher TIBC and UIBC, suggesting a possible
role of iron in the pathogenesis of allergic fungal rhinosinusitis.
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Introduction
Rhinosinusitis is an inflammation of the mucous
membrane lining the nasal and paranasal sinuses,
caused by either bacterial, fungal, or viral infections or
other non‑infectious causes, such as allergy [1]. Allergic
fungal rhinosinusitis is a distinct and frequent form of
chronic rhinosinusitis seen in atopic individuals. The
disease is distinguished by the presence of eosinophilic
mucin containing fungal hyphae in the paranasal
sinuses with the absence of invasion into sinus tissue.
Despite the extensive studies conducted in the past
years, many controversies exist regarding the definition
and pathogenesis of allergic fungal rhinosinusitis,
making it difficult to establish uniform diagnostic and
management guidelines [2].
In recent years, the critical role of iron in microbial
growth and pathogenesis has gained growing attention.
Iron is a fundamental factor in the growth, virulence,
and pathogenicity of all infectious microorganisms,
including fungi. Because of its toxic effects, free
iron is kept in low concentration in the body by
combining with iron‑binding proteins, as ferritin and
heme compounds (intracellular) or transferrin and
lactoferrin (extracellular) [3,4]. The low concentration
of free iron in the plasma and other tissues represents
a central protective mechanism against invading

pathogens [5–7]. Therefore, thriving human pathogens
must have mechanisms to battle with the host for its
tightly bound iron. Consecutively, host defense strategies
have evolved to hold iron from invasive pathogens [8,9].
The growth and survival of fungi like Aspergillus
fumigatus and Zygomycetes in serum were reported to
be associated with the removal of iron from transferrin
and other iron‑containing proteins, thus providing
increased available free iron [5,8,10,11].
Iron uptake by fungi is achieved by specific uptake
systems. In the first pathway, the ferric form is reduced to
ferrous iron using cell surface reductase (ferroxidases),
which is then interiorized by the high‑affinity iron
permease. The second pathway uses high‑affinity
iron‑binding siderophores. Finally, a third mechanism
is related to a fungal heme oxygenase, which takes up
iron from heme [12].
There is a debate concerning serum iron markers in
fungal infections in patients with different diseases, and
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so far, none has assessed their level in allergic fungal
rhinosinusitis. Therefore, this study aimed to detect
whether allergic fungal rhinosinusitis is associated
with alterations of serum iron markers.

Patients and methods
The study was conducted in Assiut University,
Departments of Otorhinolaryngology and Clinical
Pathology. The Ethics Committee of the Faculty of
Medicine, Assiut University reviewed and approved
the study protocol (IRB. No. 17300110). Written
informed consent was obtained from all patients.
All patients with allergic fungal rhinosinusitis and
patients with allergic nasal polyps admitted to the
Department of Otorhinolaryngology during the period
from March 2017 to September 2019 were included in
the study. Patients with iron deficiency anemia, anemia
of chronic disease, iron metabolic disorders, liver
diseases (cirrhosis, hepatitis, or failure), or pregnancy
were excluded from the study.
This study was performed on 66 patients, 46 males
and 20 females. They were classified into two groups;
group A included 35 patients who had allergic nasal
polyps: 28 males (80%) and 7 females (20%) with
a mean age of 41±14 years, and group B included
31 patients who had allergic fungal rhinosinusitis
diagnosed according to the criteria of Bent and
Kuhn [13]. This group included 18 males (58.1%) and
13 females (41.9%) with a mean age of 29.8±12 years.
Computerized tomography was performed for all
patients using bone and soft tissue window settings,
3 mm thickness, coronal, axial, and sagittal cuts,
without contrast. Lund–Mackay score was used for
radiologic staging of chronic rhinosinusitis [14].
Each sinus was assigned a value of 0 (totally patent),
1 (partially opacified), or 2 (completely opacified). The
osteomeatal complex was scored either 0 (not occluded)
or 2 (occluded). The maximum score for each side is
12, with a total score of 24. Lund–Mackay scores of 4
or higher considerably support the clinical diagnosis
of chronic rhinosinusitis, while the lower scores are
indefinite [15].
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capacity (UIBC) and transferrin saturation (TSAT)
were
calculated
from
[TIBC-Iron=UIBC]
and [(Iron ÷ TIBC)×100=TSAT].

Results
The computerized tomographic score of the patients’
groups

The radiological scores of both groups are summarized
in Table 1. Scores of different sinuses were comparable
between the two groups, except for the left maxillary
sinus. Most of the patients scored 20 or more bilaterally.
Comparison of the levels of serum iron markers
between the patients’ groups

The mean serum iron level was 71.2±4.6 in patients
with nasal polyps and 76.7±5.7 in patients with allergic
fungal rhinosinusitis with no significant difference.
Additionally, TIBC in the allergic fungal rhinosinusitis
group was significantly higher than the nasal polyps
group (331.7±6 vs. 291.8±7, P<0.0001). Similarly,
UIBC was higher in the allergic fungal rhinosinusitis
patients (255±7 vs. 220.6±8, P=0.002), with no
significant difference in the TSAT between the two
groups. Results are shown in Table 2 and Fig. 1.
None of the tested iron markers showed any
significant correlation with the total radiologic score
in either nasal polyps or allergic fungal rhinosinusitis
patients (Table 3).

Discussion
There is an ongoing competition for iron among
microorganisms and between the microorganisms and
their hosts during infection and commensal carriage.
Iron uptake during infection is needed for fungus
Figure 1

Measurement of serum iron markers

Two milliliters of blood were collected on plain
tubes, left for 10 min to clot, and then centrifuged at
3000 rpm for 5 min After centrifugation, the serum
was separated into aliquots. Serum iron and total
iron‑binding capacity (TIBC) were freshly assayed
in serum using Dimension® Rxl Max® integrated
chemistry
system.
Unsaturated
iron‑binding

Total iron‑binding capacity levels of patients with nasal polyps and
allergic fungal rhinosinusitis.
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Table 1 CT scores of patients with nasal polyps and patients
with allergic fungal rhinosinusitis
Scores

Nasal
polyps (n=35)

RT maxillary
0
2 (5.7%)
1
7 (20%)
2
26 (74.3%)
LT maxillary
0
2 (5.7%)
1
10 (28.6%)
2
23 (65.7%)
RT OMC
0
0 (0%)
1
2 (5.7%)
2
33 (94.3%)
LT OMC
0
2 (5.7%)
1
2 (5.7%)
2
31 (88.6%)
RT anterior ethmoid
0
0 (0%)
1
3 (8.6%)
2
32 (91.4%)
LT anterior ethmoid
0
1 (2.9%)
1
2 (5.7%)
2
32 (91.4%)
RT posterior ethmoid
0
1 (2.9%)
1
1 (2.9%)
2
33 (94.3%)
LT posterior ethmoid
0
1 (2.9%)
1
2 (5.7%)
2
32 (91.4%)
RT sphenoid
0
8 (22.9%)
1
7 (20%)
2
20 (57.1%)
LT sphenoid
0
11 (31.4%)
1
7 (20%)
2
17 (48.6%)
RT frontal
0
6 (17.1%)
1
1 (2.9%)
2
28 (80%)
LT frontal
0
3 (8.6%)
1
2 (5.7%)
2
30 (85.7%)
RT total
0
0 (0%)
4
1 (2.9%)
6
1 (2.9%)
8
2 (5.7%)
9
2 (5.7%)
10
11 (31.4%)
11
5 (14.3%)

Fungal
rhinosinusitis (n=31)
3 (9.7%)
4 (12.9%)
24 (77.4%)
4 (12.9%)
1 (3.2%)
26 (83.9%)

Table 1 Contd...
Scores

Nasal
polyps (n=35)

Fungal
rhinosinusitis (n=31)

12
LT total
0
4
5
7
8
9
10
11
12
Total
6
12
15
16
17
18
19
20
21
22
23

13 (37.1%)

14 (45.2%)

1 (2.9%)
0 (0%)
0 (0%)
3 (8.6%)
3 (8.6%)
4 (11.4%)
5 (14.3%)
4 (11.4%)
15 (42.9%)

1 (3.2%)
1 (3.2%)
1 (3.2%)
1 (3.2%)
0 (0%)
3 (9.7%)
5 (16.1%)
2 (6.5%)
17 (54.8%)

1 (3.2%)
1 (3.2%)
1 (3.2%)
2 (6.5%)
1 (3.2%)
0 (0%)
4 (12.9%)
1 (3.2%)
2 (6.5%)
5 (16.15%)
2 (6.5%)

1 (2.9%)
1 (2.9%)
1 (2.9%)
0 (0%)
4 (11.4%)
1 (2.9%)
2 (5.7%)
5 (14.3%)
3 (8.6%)
2 (5.7%)
4 (11.4%)

11 (35.5%)

11 (31.4%)

P

0.7

0.02

1 (3.2%)
0 (0%)
30 (96.8%)

0.2

1 (3.2%)
0 (0%)
30 (96.8%)

0.3

2 (6.5%)
0 (0%)
29 (93.5%)

0.09

1 (3.2%)
2 (6.5%)
28 (90.3%)

0.99

3 (9.7%)
0 (0%)
28 (90.3%)

0.3

3 (9.7%)
3 (9.7%)
25 (80.6%)

0.4

6 (19.4%)
2 (6.5%)
23 (74.1%)

0.2

5 (16.1%)
3 (9.7%)
23 (74.2%)

0.1

6 (19.4%)
3 (9.7%)
22 (71%)

0.5

6 (19.4%)
4 (12.9%)
21 (67.7%)

0.2

1 (3.2%)
1 (3.2%)
1 (3.2%)
0 (0%)
3 (9.7%)
5 (16.1%)
6 (19.4%)

0.7

24

P

0.6

0.5

Bold value indicates significant P value (<0.05). CT, computed
tomography; LT, left; OMC, osteomeatal complex; RT, right. Data
are presented as number (percent). Chi‑square test, a significant
P value is less than 0.05.

colonization and proliferation and is thus considered a
key virulence factor [16].

Contd...

Serum inhibits the growth of most fungi because free
iron concentrations in serum are too low to support
growth. In sites where iron concentrations are low, the
growth of microorganisms is allowed by the production
of siderophores, which are chelating agents produced to
retrieve iron from the environment [17–19]. Proteins such
as transferrin and lactoferrin are utilized by hosts to gain
and transport iron. Such proteins can slightly withhold
the metal from the siderophores of invading bacteria and
fungi [20]. In response to the invasion of microorganisms,
the already free iron levels in the blood and tissue fluids
of the host are further reduced through this hypoferremic
response [21,22]. This competition plays a significant role
in determining the fate of infectious diseases [23].
Host iron sequestration, which occurs with ‘stress
hypoferremia’ in response to acute infection or
injury [24,25], reverses this pathogenic effect
and restores the antimicrobial properties of host
serum [26,27]. This decrease in iron availability, or
‘iron‑withholding’, may serve as a defense mechanism
after infection or other stressful events [28].
This study aimed to detect whether allergic fungal
rhinosinusitis is associated with alterations of serum
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Table 2 Comparison of the serum iron markers between
patients with nasal polyps and allergic fungal rhinosinusitis
Variables
Iron (g/dl)
TIBC (U/dl)
UIBC
TSAT (%)

Nasal polyps
(n=35)

Fungal
rhinosinusitis (n=31)

P

71.2±4.6
291.8±7
220.6±8

76.7±5.7
331.7±6
255±7

0.4
<0.0001
0.002

24.7

23

0.5

Bold values indicate significant P value (<0.05) and highly
significant P value (<0.001). TIBC, total iron‑binding capacity; TSAT,
transferrin saturation; UIBC, unsaturated iron‑binding capacity.
Independent sample t‑test, a significant P value is less than 0.05.
Table 3 Correlations of iron markers with the total CT
scores in patients with nasal polyps and allergic fungal
rhinosinusitis
Variable
Iron
TIBC
UIBC
TSAT

Total score in
nasal polyps

Total score in
fungal rhinosinusitis

r=−0.2
P=0.1
r=0.01
P=0.5
r=0.2
P=0.2
r=0.1

r=−0.2
P=0.2
r=0.2
P=0.2
r=0.01
P=0.5
r=−0.02

P=0.2

P=0.5

CT, computed tomography; TIBC, total iron‑binding capacity;
TSAT, transferrin saturation; UIBC, unsaturated iron‑binding
capacity. Kendall’s Tau correlation, a significant P value is less
than 0.05.

iron markers. Levels of serum iron markers were
compared between patients with allergic fungal
rhinosinusitis and with allergic nasal polyps. No
significant differences were observed in the serum
iron levels and the TAST between the two groups.
Meanwhile, TIBC and UIBC in fungal rhinosinusitis
patients were substantially higher than those in allergic
nasal polyps patients.
Gifford et al. [29] showed that A. fumigatus could grow
in media containing up to 80% human serum, indicating
that it has an efficient mechanism for obtaining iron
from serum components. Survival of A. fumigatus and
other species in serum is associated with the removal
of iron from transferrin and other iron‑containing
proteins [8]. This could explain the higher TIBC found
in our allergic fungal rhinosinusitis patients than in the
allergic polyps group. Meanwhile, finding no major
differences between the two patients’ groups may be
explained by a previous conclusion that an elevation
of TIBC occurs before the decline of the serum iron,
signifying a compensatory mechanism to mobilize all
tissue iron traces to maintain normal erythropoiesis.
The results of a study on 109 liver transplantation
patients revealed that the levels of serum iron markers
were independently associated with an increased risk
of bacterial, fungal, and viral infections. That study also
reported no significant differences in serum iron levels
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between patients who developed fungal infections and
those who did not. Transferrin is the major extracellular
transport protein and is usually only 30–40% saturated.
Increases and decreases in tissue iron stores correspond
to increases and decreases in transferrin saturation,
respectively [30]. In line with their results, our findings
indicate that TIBC and UIBC are more informative
than measuring serum iron levels, which do not
necessarily reflect the level of iron stores.
Contradictory to our results, earlier studies [31,32]
reported an association between decreased TIBC
and fungal infections in patients with hematological
malignancies. In‑vitro studies demonstrated that an
increase in transferrin saturation probably promotes
fungal growth [33–35] by increasing iron supply [35].
Increased transferrin saturation might be due to
a decrease in transferrin concentrations without a
parallel reduction in serum iron concentration as an
acute‑phase reactant protein response occurring in
chronic disorders [32].
None of the tested iron markers showed any significant
correlation with the total radiologic score in either
nasal polyps or allergic fungal rhinosinusitis patients.
This may be because most of the enrolled patients
scored 20 or more bilaterally.

Conclusion
Allergic fungal rhinosinusitis is associated with higher
TIBC and UIBC, suggesting a possible role of iron in
the pathogenesis of allergic fungal rhinosinusitis.
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